IL122191A0 - Pharmaceutical compositions containing substituted benzopyrans - Google Patents

Pharmaceutical compositions containing substituted benzopyrans

Info

Publication number: IL122191A0
Authority: IL; Israel
Prior art keywords: pharmaceutical compositions; compositions containing; containing substituted; substituted benzopyrans; benzopyrans
Prior art date: 1995-08-10

Application number

IL12219196A

Other languages

English (en)

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-10

Filing date

1996-07-29

Publication date

1998-04-05

1996-07-29 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

1998-04-05 Publication of IL122191A0 publication Critical patent/IL122191A0/xx

Links

150000001562 benzopyrans Chemical class 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

IL12219196A 1995-08-10 1996-07-29 Pharmaceutical compositions containing substituted benzopyrans IL122191A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US209895P	1995-08-10	1995-08-10
PCT/US1996/012430 WO1997005875A2 (en)	1995-08-10	1996-07-29	A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus

Publications (1)

Publication Number	Publication Date
IL122191A0 true IL122191A0 (en)	1998-04-05

Family

ID=21699238

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12219196A IL122191A0 (en)	1995-08-10	1996-07-29	Pharmaceutical compositions containing substituted benzopyrans

Country Status (15)

Country	Link
EP (1)	EP0851757A2 (cs)
JP (1)	JPH11510508A (cs)
KR (1)	KR19990036290A (cs)
CN (1)	CN1192683A (cs)
AU (1)	AU724989B2 (cs)
BG (1)	BG102235A (cs)
CA (1)	CA2221241A1 (cs)
CZ (1)	CZ32998A3 (cs)
EA (1)	EA199800177A1 (cs)
HU (1)	HUP9802543A2 (cs)
IL (1)	IL122191A0 (cs)
NO (1)	NO980556D0 (cs)
NZ (1)	NZ313874A (cs)
SK (1)	SK16498A3 (cs)
WO (1)	WO1997005875A2 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9711683D0 (en) *	1997-06-05	1997-08-06	Smithkline Beecham Plc	Composition
GB9712866D0 (en) *	1997-06-18	1997-08-20	Smithkline Beecham Plc	Novel method of treatment
GB2335597A (en) *	1998-03-27	1999-09-29	Glaxo Group Ltd	Stereoisomers of Troglitazone in the Treatment of Diabetes
DE69919707T2 (de)	1998-06-19	2005-09-01	Chiron Corp., Emeryville	Glycogen synthase kinase 3 inhibitoren
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
FR2838968A1 (fr) *	2002-04-30	2003-10-31	Lipha	Association d'insuline et d'un derive de thiazolidinedione et son utilisation pour traiter le diabete

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6051189A (ja) *	1983-08-30	1985-03-22	Sankyo Co Ltd	チアゾリジン誘導体およびその製造法
US4873255A (en) *	1987-02-04	1989-10-10	Sankyo Company Limited	Thiazolidinone derivatives, their preparation and their use
US5457109A (en) *	1993-09-15	1995-10-10	Warner-Lambert Company	Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
TW438587B (en)	1995-06-20	2001-06-07	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes

1996
- 1996-07-29 JP JP9508479A patent/JPH11510508A/ja not_active Ceased
- 1996-07-29 CN CN96196191A patent/CN1192683A/zh active Pending
- 1996-07-29 IL IL12219196A patent/IL122191A0/xx unknown
- 1996-07-29 HU HU9802543A patent/HUP9802543A2/hu unknown
- 1996-07-29 WO PCT/US1996/012430 patent/WO1997005875A2/en not_active Ceased
- 1996-07-29 NZ NZ313874A patent/NZ313874A/xx unknown
- 1996-07-29 KR KR1019980700958A patent/KR19990036290A/ko not_active Ceased
- 1996-07-29 EA EA199800177A patent/EA199800177A1/ru unknown
- 1996-07-29 CA CA002221241A patent/CA2221241A1/en not_active Abandoned
- 1996-07-29 AU AU66411/96A patent/AU724989B2/en not_active Withdrawn - After Issue
- 1996-07-29 EP EP96926171A patent/EP0851757A2/en not_active Withdrawn
- 1996-07-29 SK SK164-98A patent/SK16498A3/sk unknown
- 1996-07-29 CZ CZ98329A patent/CZ32998A3/cs unknown
1998
- 1998-02-05 BG BG102235A patent/BG102235A/xx unknown
- 1998-02-09 NO NO980556A patent/NO980556D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO1997005875A3 (en)	1997-03-27
CA2221241A1 (en)	1997-02-20
JPH11510508A (ja)	1999-09-14
NO980556L (no)	1998-02-09
CZ32998A3 (cs)	1998-10-14
HUP9802543A2 (hu)	1999-07-28
NO980556D0 (no)	1998-02-09
WO1997005875A2 (en)	1997-02-20
EA199800177A1 (ru)	1998-10-29
BG102235A (en)	1998-09-30
AU6641196A (en)	1997-03-05
KR19990036290A (ko)	1999-05-25
SK16498A3 (en)	1999-03-12
NZ313874A (en)	2000-09-29
CN1192683A (zh)	1998-09-09
EP0851757A2 (en)	1998-07-08
AU724989B2 (en)	2000-10-05

Publication	Publication Date	Title
SG49956A1 (en)	1998-06-15	Pharmaceutical compositions containing irbesartan
NZ304982A (en)	1999-03-29	Pyridinyloxy- or pyridinylamino-acetamide derivatives; pharmaceutical compositions
HUP9802999A3 (en)	1999-05-28	Pharmaceutical composition containing n-propargyl-1-aminoindan
HUP9602056A3 (en)	2000-09-28	Novel pharmaceutical composition containing phenofibrate
HU9601698D0 (en)	1996-08-28	Pharmaceutical composition
EG20989A (en)	2000-08-30	Cleasing compositions
ZA967827B (en)	1997-03-18	Pharmaceutical compositions
ZA962214B (en)	1996-10-07	Pharmaceutical composition
GB9519667D0 (en)	1995-11-29	Pharmaceutical composition
EG24294A (en)	2009-01-08	Pharmaceutical compositions
ZA963590B (en)	1996-11-19	Pharmaceutical composition
GB9506382D0 (en)	1995-05-17	Pharmaceutical compositions
ZA96525B (en)	1996-08-06	Novel pharmaceutical compositions
GB9513972D0 (en)	1995-09-06	Pharmaceutical compositions
IL118382A0 (en)	1996-09-12	Substituted benzopyrans their preparation and pharmaceutical compositions containing them
ZA961051B (en)	1996-09-11	Pharmaceutical composition
GB9525194D0 (en)	1996-02-07	Pharmaceutical composition
ZA964193B (en)	1996-12-04	Pharmaceutical composition
HU9602822D0 (en)	1996-11-28	Pharmaceutical composition
ZA95736B (en)	1995-10-04	Pharmaceutical composition
SI0828733T1 (en)	2002-04-30	Benzopyrans and pharmaceutical compositions containing them
HUP9602732A2 (en)	1997-09-29	Pharmaceutical composition comprising lanperisone
GB9517133D0 (en)	1995-10-25	Pharmaceutical compositions
GB9519157D0 (en)	1995-11-22	Pharmaceutical compositions
GB9511480D0 (en)	1995-08-02	Pharmaceutical compositions